CD274 and neoplasm: PD-L1 expression in tumor cells was observed in 84.2% (16/19) of MCCHL cases, 100% (11/11) of NSCHL cases, 66.6% (4/6) of LDCHL cases, and 66.6% (2/3) of LRCHL cases.